SCHEMBL2454543

SCHEMBL2454543

Cc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADCY10 Q96PN6 2/20 0.44
CCR2 P41597 2/20 0.43
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
ENPP1 P22413 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR6 P50406 1/20 0.38
IDH1 O75874 1/20 0.38
ALKBH3 Q96Q83 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2463316 0.89 THRB (0.46) CCR2ENPP1KDM4EALDH1A1HTR6
SCHEMBL2456787 0.87 CCR2 (0.43) CCR2KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL2459259 0.87 CCR2 (0.51) ADCY10CCR2ALKBH3
SCHEMBL2462220 0.86 ALKBH3 (0.46) ADCY10CCR2KDM4EALDH1A1HPGD
SCHEMBL12324736 0.86 CCR2 (0.46) CCR2ALKBH3
SCHEMBL2425276 0.86 KDM4E (0.46) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL12324673 0.85 IDH1 (0.47) ADCY10CCR2ENPP1HTR6IDH1
SCHEMBL2459014 0.82 GPR52 (0.41) ALKBH3
SCHEMBL2461969 0.81 PNP (0.39) KDM4EALDH1A1HPGD
SCHEMBL2457171 0.81 ALKBH3 (0.48) CCR2ALDH1A1HPGDHTR6ALKBH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed